Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

ABLATUS THERAPEUTICS LIMITED

Company number 09812865

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
19 Oct 2018 PSC02 Notification of Nvm Private Equity Llp as a person with significant control on 19 April 2018
04 Sep 2018 SH01 Statement of capital following an allotment of shares on 10 August 2018
  • GBP 24.52579
03 Sep 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
30 Jul 2018 RP04SH01 Second filing of a statement of capital following an allotment of shares on 19 April 2018
  • GBP 23.89532
25 Jun 2018 AA Accounts for a small company made up to 31 December 2017
14 Jun 2018 AD01 Registered office address changed from 1 st James Court Whitefriars Norwich Norfolk NR3 1RU United Kingdom to 30 Broad Street Great Cambourne Cambridge CB23 6HJ on 14 June 2018
17 May 2018 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
10 May 2018 SH01 Statement of capital following an allotment of shares on 19 April 2018
  • GBP 23.89208
  • ANNOTATION Clarification a second filed SH01 was registered on 30/07/2018.
04 Apr 2018 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
20 Mar 2018 RP04SH01 Second filing of a statement of capital following an allotment of shares on 23 May 2016
  • GBP 14.20
19 Feb 2018 SH01 Statement of capital following an allotment of shares on 30 January 2018
  • GBP 16.14337
19 Feb 2018 SH01 Statement of capital following an allotment of shares on 30 January 2018
  • GBP 16.14013
16 Feb 2018 SH01 Statement of capital following an allotment of shares on 19 December 2017
  • GBP 15.80644
16 Feb 2018 MR04 Satisfaction of charge 098128650001 in full
29 Nov 2017 PSC07 Cessation of Norfolk & Norwich University Hospital Nhs Foundation Trust as a person with significant control on 11 October 2017
29 Nov 2017 PSC07 Cessation of Health Enterprise East Ltd as a person with significant control on 11 October 2017
26 Oct 2017 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
21 Oct 2017 SH01 Statement of capital following an allotment of shares on 11 October 2017
  • GBP 15.05644
16 Oct 2017 CS01 Confirmation statement made on 6 October 2017 with updates
15 Jun 2017 AA Full accounts made up to 31 December 2016
26 Oct 2016 AP01 Appointment of Professor Marcus Denis Flather as a director on 29 June 2016
20 Oct 2016 CS01 Confirmation statement made on 6 October 2016 with updates
07 Sep 2016 RP04SH01 Second filing of a statement of capital following an allotment of shares on 5 April 2016
  • GBP 14.20
01 Sep 2016 SH01 Statement of capital following an allotment of shares on 10 February 2016
  • GBP 10.75
03 Jul 2016 AA01 Current accounting period extended from 31 October 2016 to 31 December 2016